404 related articles for article (PubMed ID: 31147370)
1. Initiation and completion rates of isoniazid preventive therapy among people living with HIV in Far-Western Region of Nepal: a retrospective cohort study.
Dhungana GP; Thekkur P; Chinnakali P; Bhatta U; Pandey B; Zhang WH
BMJ Open; 2019 May; 9(5):e029058. PubMed ID: 31147370
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of isoniazid preventive therapy among people living with HIV in Kenya: A retrospective study of routine health care data.
Karanja M; Kingwara L; Owiti P; Kirui E; Ngari F; Kiplimo R; Maina M; Masini E; Onyango E; Ngugi C
PLoS One; 2020; 15(12):e0234588. PubMed ID: 33264300
[TBL] [Abstract][Full Text] [Related]
3. Isoniazid preventive therapy: Uptake, incidence of tuberculosis and survival among people living with HIV in Bulawayo, Zimbabwe.
Nyathi S; Dlodlo RA; Satyanarayana S; Takarinda KC; Tweya H; Hove S; Matambo R; Mandewo W; Nyathi K; Sibanda E; Harries AD
PLoS One; 2019; 14(10):e0223076. PubMed ID: 31581271
[TBL] [Abstract][Full Text] [Related]
4. A prospective cohort study of outcomes for isoniazid prevention therapy: a nested study from a national QI collaborative in Uganda.
Sensalire S; Karungi Karamagi Nkolo E; Nabwire J; Lawino A; Kiragga D; Muhire M; Kadama H; Katureebe C; Namuwenge P; Musinguzi J; Calnan J; Seyoum D
AIDS Res Ther; 2020 May; 17(1):28. PubMed ID: 32460788
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effect of isoniazid preventive therapy and antiretroviral therapy on the incidence of tuberculosis in people living with HIV in Ethiopia.
Yirdaw KD; Jerene D; Gashu Z; Edginton ME; Kumar AM; Letamo Y; Feleke B; Teklu AM; Zewdu S; Weiss B; Ruff A
PLoS One; 2014; 9(8):e104557. PubMed ID: 25105417
[TBL] [Abstract][Full Text] [Related]
6. Determinants of isoniazid preventive therapy completion among people living with HIV attending care and treatment clinics from 2013 to 2017 in Dar es Salaam Region, Tanzania. A cross-sectional analytical study.
Robert M; Todd J; Ngowi BJ; Msuya SE; Ramadhani A; Sambu V; Jerry I; Mujuni MR; Mahande MJ; Ngocho JS; Maokola W
BMC Infect Dis; 2020 Apr; 20(1):276. PubMed ID: 32276618
[TBL] [Abstract][Full Text] [Related]
7. Early-phase scale-up of isoniazid preventive therapy for people living with HIV in two districts in Malawi (2017).
Nabity SA; Gunde LJ; Surie D; Shiraishi RW; Kirking HL; Maida A; Auld AF; Odo M; Jahn A; Nyirenda RK; Oeltmann JE
PLoS One; 2021; 16(4):e0248115. PubMed ID: 33793577
[TBL] [Abstract][Full Text] [Related]
8. To start or to complete? - Challenges in implementing tuberculosis preventive therapy among people living with HIV: a mixed-methods study from Karnataka, India.
Reddy MM; Thekkur P; Ramya N; Kamath PBT; Shastri SG; Kumar RBN; Chinnakali P; Nirgude AS; Rangaraju C; Somashekar N; Kumar AMV
Glob Health Action; 2020; 13(1):1704540. PubMed ID: 31937200
[No Abstract] [Full Text] [Related]
9. Coverage of isoniazid preventive therapy among people living with HIV; A retrospective cohort study in Tanzania (2012-2016).
Maokola W; Ngowi B; Lawson L; Robert M; Mahande M; Todd J; Msuya S
Int J Infect Dis; 2021 Feb; 103():562-567. PubMed ID: 33276111
[TBL] [Abstract][Full Text] [Related]
10. Assessment of Isoniazid Preventive Therapy and Incidence of Tuberculosis among People Living with Human Immunodeficiency Virus Seeking Care in an Anti-retroviral Therapy Center, Puducherry.
Kannusamy S; Sahu SK; Udayashankar C; Sarveswaran G; Roy G
Indian J Public Health; 2024 Jan; 68(1):15-20. PubMed ID: 38847627
[TBL] [Abstract][Full Text] [Related]
11. Implementation of isoniazid preventive therapy in an HIV clinic in Cambodia: high rates of discontinuation when combined with antiretroviral therapy.
van Griensven J; Choun K; Chim B; Thai S; Lorent N; Lynen L
Trop Med Int Health; 2015 Dec; 20(12):1823-31. PubMed ID: 26426387
[TBL] [Abstract][Full Text] [Related]
12. Incidence of tuberculosis among PLHIV on antiretroviral therapy who initiated isoniazid preventive therapy: A multi-center retrospective cohort study.
Kazibwe A; Oryokot B; Mugenyi L; Kagimu D; Oluka AI; Kato D; Ouma S; Tayebwakushaba E; Odoi C; Kakumba K; Opito R; Mafabi CG; Ochwo M; Nkabala R; Tusiimire W; Kateeba Tusiime A; Alinga SB; Miya Y; Etukoit MB; Biraro IA; Kirenga B
PLoS One; 2022; 17(5):e0266285. PubMed ID: 35576223
[TBL] [Abstract][Full Text] [Related]
13. Successful implementation of isoniazid preventive therapy at a pediatric HIV clinic in Tanzania.
Hunter OF; Kyesi F; Ahluwalia AK; Daffé ZN; Munseri P; von Reyn CF; Adams LV
BMC Infect Dis; 2020 Oct; 20(1):738. PubMed ID: 33028260
[TBL] [Abstract][Full Text] [Related]
14. The protective effect of isoniazid preventive therapy on tuberculosis incidence among HIV positive patients receiving ART in Ethiopian settings: a meta-analysis.
Geremew D; Endalamaw A; Negash M; Eshetie S; Tessema B
BMC Infect Dis; 2019 May; 19(1):405. PubMed ID: 31077133
[TBL] [Abstract][Full Text] [Related]
15. Completion of isoniazid preventive therapy for latent tuberculosis infection among children and adolescents compared to adults living with HIV in Kinshasa, Democratic Republic of the Congo.
Bidashimwa D; Ditekemena JD; Sigwadhi LN; Nkuta LM; Engetele E; Kilundu A; Chabikuli ON; Nachega JB
Trop Med Int Health; 2024 Feb; 29(2):88-95. PubMed ID: 38123460
[TBL] [Abstract][Full Text] [Related]
16. Brief Report: High Programmatic Isoniazid Preventive Therapy (IPT) Use in Pregnancy Among HIV-Infected Women.
LaCourse SM; Wagner AD; Cranmer LM; Copeland A; Maleche-Obimbo E; Richardson BA; Matemo D; Kinuthia J; John-Stewart G
J Acquir Immune Defic Syndr; 2019 Sep; 82(1):41-45. PubMed ID: 31408031
[TBL] [Abstract][Full Text] [Related]
17. Drop-offs in the isoniazid preventive therapy cascade among children living with HIV in western Kenya, 2015-2019.
Onyango DO; van der Sande MAB; Yuen CM; Mecha J; Matemo D; Oele E; Kinuthia J; John-Stewart G; LaCourse SM
J Int AIDS Soc; 2022 Aug; 25(8):e25939. PubMed ID: 35927793
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of isoniazid preventative therapy in reducing incidence of active tuberculosis among people living with HIV/AIDS in public health facilities of Addis Ababa, Ethiopia: a historical cohort study.
Semu M; Fenta TG; Medhin G; Assefa D
BMC Infect Dis; 2017 Jan; 17(1):5. PubMed ID: 28049455
[TBL] [Abstract][Full Text] [Related]
19. Trend analysis of tuberculosis case notifications with scale-up of antiretroviral therapy and roll-out of isoniazid preventive therapy in Zimbabwe, 2000-2018.
Takarinda KC; Harries AD; Mutasa-Apollo T; Sandy C; Choto RC; Mabaya S; Mbito C; Timire C
BMJ Open; 2020 Apr; 10(4):e034721. PubMed ID: 32265241
[TBL] [Abstract][Full Text] [Related]
20. Contact evaluation and isoniazid preventive therapy among close and household contacts of tuberculosis patients in Lima, Peru: an analysis of routine data.
Otero L; Battaglioli T; Ríos J; De la Torre Z; Trocones N; Ordoñez C; Seas C; Van der Stuyft P
Trop Med Int Health; 2020 Mar; 25(3):346-356. PubMed ID: 31758837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
